Toggle Main Menu Toggle Search

Open Access padlockePrints

Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency

Lookup NU author(s): Professor Robert Taylor

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Acyl-CoA dehydrogenase 9 (ACAD9) is an assembly factor for mitochondrial respiratory chain Complex I (CI), and ACAD9 mutations are recognized as a frequent cause of CI deficiency. ACAD9 also retains enzyme ACAD activity for long-chain fatty acids in vitro, but the biological relevance of this function remains controversial partly because of the tissue specificity of ACAD9 expression: high in liver and neurons and minimal in skin fibroblasts. In this study, we hypothesized that this enzymatic ACAD activity is required for full fatty acid oxidation capacity in cells expressing high levels of ACAD9 and that loss of this function is important in determining phenotype in ACAD9-deficient patients. First, we confirmed that HEK293 cells express ACAD9 abundantly. Then, we showed that ACAD9 knockout in HEK293 cells affected long-chain fatty acid oxidation along with Cl, both of which were rescued by wild type ACAD9. Further, we evaluated whether the loss of ACAD9 enzymatic fatty acid oxidation affects clinical severity in patients with ACAD9 mutations. The effects on ACAD activity of 16 ACAD9 mutations identified in 24 patients were evaluated using a prokaryotic expression system. We showed that there was a significant inverse correlation between residual enzyme ACAD activity and phenotypic severity of ACAD9-deficient patients. These results provide evidence that in cells where it is strongly expressed, ACAD9 plays a physiological role in fatty acid oxidation, which contributes to the severity of the phenotype in ACAD9-deficient patients. Accordingly, treatment of ACAD9 patients should aim at counteracting both CI and fatty acid oxidation dysfunctions.


Publication metadata

Author(s): Schiff M, Haberberger B, Xia CW, Mohsen AW, Goetzman ES, Wang YD, Uppala R, Zhang YX, Karunanidhi A, Prabhu D, Alharbi H, Prochownik EV, Haack T, Haberle J, Munnich A, Rötig A, Taylor RW, Nicholls RD, Kim JJ, Prokisch H, Vockley J

Publication type: Article

Publication status: Published

Journal: Human Molecular Genetics

Year: 2015

Volume: 24

Issue: 11

Pages: 3238-3247

Print publication date: 01/06/2015

Online publication date: 26/02/2015

Acceptance date: 23/01/2015

ISSN (print): 0964-6906

ISSN (electronic): 1460-2083

Publisher: Oxford University Press

URL: http://dx.doi.org/: 10.1093/hmg/ddv074

DOI: 10.1093/hmg/ddv074


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Philippe Foundation
Children's Hospital of Pittsburgh of UPMC Research Advisory Committee
Societe Francaise de Pediatrie
01GM1207German Federal Ministry of Education and Research (BMBF, Bonn, Germany)
01GM1113CGerman Federal Ministry of Education and Research (BMBF, Bonn, Germany)
096919/Z/11/ZWellcome Trust
GM29076NIH
NIH R01 DK78775PHS
R01 DK090242NIH

Share